The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Fecal microbiota transplantation followed by anti–PD-1 treatment in patients with advanced melanoma.
 
Wilson H. Miller
Honoraria - Amgen; Bristol Myers Squibb Foundation; EMD Serono; GlaxoSmithKline; Merck; Mylan; Novartis; Roche; Sanofi; Sanofi
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; EMD Serono; GlaxoSmithKline; Merck; Mylan; Novartis; Roche; Sanofi
Research Funding - Alkermes (Inst); Amgen (Inst); Array BioPharma (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Canada Research Society (Inst); Canadian Cancer Society Research Institute (CCSRI) (Inst); Canadian Institutes of Health Research (CIHR) (Inst); Esperas Pharma (Inst); Exelixis (Inst); GlaxoSmithKline (Inst); Incyte (Inst); MedImmune (Inst); Merck (Inst); MethylGene (Inst); Mimic Technologies (Inst); Novartis (Inst); Ocellaris Pharma (Inst); Pfizer (Inst); Roche (Inst); Samuel Waxman Cancer Research Foundation (Inst); Sanofi (Inst); TERRY FOX RESEARCH INSTITUTE (Inst)
 
Bertrand Routy
Honoraria - AstraZeneca Canada; Bayer; Bristol-Myers Squibb; Da Volterra; Illumina; Kaleido Biosciences; Merck; Pfizer; Sanofi; Vedanta Biosciences
Consulting or Advisory Role - AstraZeneca Canada; Bayer; Bristol-Myers Squibb; Da Volterra; Illumina; Kaleido Biosciences; Merck; Pfizer; Sanofi; Vedanta Biosciences
Research Funding - Amgen; AstraZeneca Canada; Bristol-Myers Squibb; Da Volterra; Imagia; Kaleido Biosciences; Merck; Sanofi; Vedanta Biosciences
 
Rahima Jamal
Research Funding - Bristol-Myers Squibb (Inst); Iovance Biotherapeutics (Inst); Merck Sharp & Dohme (Inst)
 
D. Scott Ernst
Consulting or Advisory Role - Bristol-Myers Squibb; Merck; Novartis Canada Pharmaceuticals Inc; Pfizer; Sanofi
Research Funding - Pfizer
 
Diane Logan
No Relationships to Disclose
 
Khashayar Esfahani
Honoraria - AstraZeneca Canada; Bristol-Myers Squibb/Sanofi; EMD Serono; Gilead Sciences; Merck; Novartis; Pfizer; Sanofi
Research Funding - Pfizer
 
Karl Belanger
Research Funding - Bristol-Myers Squibb (Inst)
 
Arielle Elkrief
Other Relationship - Canadian Institutes of Health Research (CIHR); Cedars Cancer Center; Royal College of Surgeons and Physicians of Canada
 
Rejean Lapointe
Patents, Royalties, Other Intellectual Property - National Institute of Health (NIH)
 
Pamela Thebault
No Relationships to Disclose
 
Mayra Ponce
No Relationships to Disclose
 
Seema Nair Parvathy
No Relationships to Disclose
 
Meriem Messaoudene
Patents, Royalties, Other Intellectual Property - patent pending on anticancer use of castalagin use
 
Micheal Silverman
Speakers' Bureau - Gilead Sciences; ViiV Healthcare
Research Funding - Finch Therapeutics; Seres Therapeutics
 
Saman Maleki
No Relationships to Disclose
 
John Gordon Lenehan
Consulting or Advisory Role - Novartis
Travel, Accommodations, Expenses - Merck